Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keverprazan vs esomeprazole for NSAID-associated gastric ulcers
ChiCTR2500114194Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of keverprazan in gastric ulcer (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Proportion of subjects with healed NSAID-associated gastric ulcers and Relief rate of nausea. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
keverprazan
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on ChiCTR2500114194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114194.